Immuneering Corporation

NASDAQ:IMRX

Biotechnology

Healthcare
$3.50 -0.14%

-$0.01 today

Market cap
$226.67M
Beta
0.38
P/E (TTM)
-3.6
EPS (TTM)
-$1.24
52W Low $2.29High $10.08

Volume 0.73M

Average 1.38M

Balance Sheet

Inspect the capital base behind the business.

Assets

$231.99M

FY 2025 · Annual

+340.1% YoY

Liabilities

$13.50M

FY 2025 · Annual

+19.2% YoY

Equity

$218.48M

FY 2025 · Annual

+427.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents74.89M72.64M59.41M36.14M128.65M
Short-term Investments74.31M32.89M26.26M044.19M
Net Receivables246.04K12.42K000
Inventory00000
Other Current Assets03.21M3.42M3.44M3.41M
Total Current Assets152.33M108.75M89.08M39.59M176.25M
Property, Plant & Equipment (Net)6.13M5.78M5.4M4.79M4.26M
Goodwill6.7M6.69M6.69M6.69M6.69M
Intangible Assets439K408.95K379.68K350.41K321.15K
Long-term Investments996.56K0000
Tax Assets00000
Other Non-current Assets102.13K743.7K1.03M1.3M44.47M
Total Non-current Assets14.37M13.62M13.5M13.13M55.74M
Total Assets166.7M122.37M102.58M52.71M231.99M
Account Payables1.39M3.15M2.11M1.96M1.54M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities2.92M3.65M3.89M3.82M4.54M
Total Current Liabilities5.63M8.05M7.85M7.5M10.07M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities5.09M4.46M4.16M3.82M3.43M
Total Liabilities10.72M12.52M12.01M11.33M13.5M
Common Stock26.32K26.42K29.27K31.05K64.65K
Retained Earnings(59.27M)(109.79M)(163.26M)(224.3M)(280.32M)
Accumulated OCI(49.01K)(30.12K)(778)081.33K
Other Stockholders Equity00010
Minority Interest00000
Total Equity155.98M109.85M90.58M41.39M218.48M
Total Debt5.36M4.84M4.46M4.16M3.82M
Net Debt(69.52M)(67.8M)(54.94M)(31.98M)(124.82M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$47.3M
Short-term Investments$109.4M
Other Current$161.3B
Total Current Assets$161.4B
PP&E (Net)$4.2B
Goodwill$6.7B
Intangible Assets$313.8M
Long-term Investments$42.0M
Other Non-current$42.2B
Total Non-current Assets$53.4B
Total Assets$214.8B

Analysis

Selected assets total $214.8B for Latest. The largest visible component is Other Current at $161.3B, about 75.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 9, 2026
3Initial statement of beneficial ownershipNov 9, 2026
10-QQuarterly reportOct 29, 2026
8-KCurrent reportOct 29, 2026

How much cash does IMRX have?

Immuneering Corporation (IMRX) reported $128.65M in cash and equivalents in fiscal 2025.

How much debt does IMRX carry?

Immuneering Corporation (IMRX) reported $3.82M of total debt, with net debt of -$124.82M.